Epilepsy is not rare. Around 50 million people worldwide have the condition, and roughly 1 in 26 people will develop it at some point during their lifetime. That makes epilepsy one of the most common neurological disorders on the planet. Still, some specific types of epilepsy are genuinely rare, which is where the question gets more nuanced.
How Common Epilepsy Is by the Numbers
At any given time, between 4 and 10 out of every 1,000 people have active epilepsy, meaning they either experience ongoing seizures or take medication to prevent them. Each year, roughly 68 new cases are diagnosed per 100,000 people globally. In the United States alone, about 3.4 million people are living with active epilepsy: 2.9 million adults and 456,000 children.
To put that in perspective, epilepsy is more common than Parkinson’s disease and multiple sclerosis combined. It sits in the same frequency range as conditions like rheumatoid arthritis. So while most people don’t personally know someone with epilepsy (or don’t know they do, since many people manage it privately), it is far from uncommon.
Lifetime Risk Varies by Sex and Age
Your cumulative risk of developing epilepsy increases as you age. By age 50, the lifetime risk is about 1.6%. By age 80, it climbs to 3.0%. Men face slightly higher odds than women: roughly 1 in 21 males will develop epilepsy at some point, compared to 1 in 28 females.
The age pattern has also shifted over time. Epilepsy used to be thought of primarily as a childhood condition, but the incidence in older adults now exceeds that in children, at least in developed countries. People over 65 develop epilepsy at a rate of 100 to 140 per 100,000, which is roughly double the overall population rate. In people over 80, the rate may be even higher. This shift is partly driven by stroke, dementia, and other age-related brain conditions that can trigger seizures. A large UK study found that only 25% of new epilepsy cases were in people under 15.
Where You Live Changes the Odds
About 80% of people with epilepsy live in low- and middle-income countries. That’s not just because those countries have larger populations. The actual rates of epilepsy are higher in poorer regions, driven by risk factors that are more common there: head injuries, birth complications, and brain infections. Rural areas are particularly affected. In wealthier countries, better prenatal care, fewer untreated infections, and lower rates of traumatic brain injury have helped push incidence down, especially in children.
Rare Epilepsy Syndromes
While epilepsy as a whole is common, it’s actually an umbrella term covering dozens of distinct syndromes. Several of these are genuinely rare by any medical definition. The World Health Organization considers a condition rare if it affects fewer than 65 to 100 people per 100,000.
- Lennox-Gastaut syndrome affects about 15 per 100,000 people. It typically begins in childhood and causes multiple seizure types that are often difficult to control.
- West syndrome (infantile spasms) has a prevalence of roughly 8 per 100,000. It appears in the first year of life and involves clusters of sudden jerking movements.
- Dravet syndrome is rarer still, with an estimated birth prevalence of 2.5 per 100,000. It starts in infancy and is associated with prolonged, fever-triggered seizures and developmental challenges.
- Pyridoxine-dependent epilepsy is extremely rare at 0.2 per 100,000, making it about 75 times less common than Lennox-Gastaut syndrome.
These rare forms tend to be more severe, harder to treat, and more likely to affect development. They account for a small fraction of all epilepsy cases but represent some of the most challenging situations families and doctors face.
Treatment Outlook
About two-thirds of people with epilepsy achieve complete seizure control with medication. Many reach that point quickly: around 40% become seizure-free within the first year of starting treatment, and by five years, 70% to 80% have reached sustained remission.
The remaining one-third develop drug-resistant epilepsy, meaning medications alone don’t fully control their seizures. For some of these people, surgery, nerve stimulation devices, or specialized diets can help. But drug-resistant epilepsy carries real risks, including a small but serious one: sudden unexpected death in epilepsy, or SUDEP. This affects roughly 1 in 1,000 adults with epilepsy per year and about 1 in 4,500 children. The risk is highest in people whose seizures remain uncontrolled, particularly those who have convulsive seizures during sleep.
Common Condition, Uneven Burden
The short answer is that epilepsy is not rare at all. It’s one of the most widespread neurological conditions in the world, affecting people of every age, background, and country. What varies enormously is the type of epilepsy, its severity, and the resources available to treat it. Someone with a common form of focal epilepsy in a high-income country has an excellent chance of living seizure-free. Someone with Dravet syndrome or someone living in a rural, low-income area faces a very different reality, even though both fall under the same diagnostic umbrella.